病毒学报

参考文献

[1]He T C,Zhou S,da Costa L T,Yu J,Kinzler K W,Vogelstein B.A simplified system for generating recombinant adenoviruses[J].Proc Natl Acad Sci U SA,1998,95(5):2509-2514.

[2]Wong H H,Jiang G,Gangeswaran R,Wang P,Wang J,Yuan M,Wang H,Bhakta V,Müller H,Lemoine NR,Wang Y.Modifification of the early gene enhancerpromoter improves the oncolytic potency of adenovirus11[J].Mol Ther,2012,20(2):306-316.

[3]Ruzsics Z,Lemnitzer F,Thirion C.Engineering adenovirus genome by bacterial artifificial chromosome(BAC)technology[J].Methods Mol Biol,2014,1089,143-158.

[4]Hokanson C A,Dora E,Donahue B A,Rivkin M,Finer M,Mendez M J.Hybrid yeast-bacteria cloning system used to capture and modify adenoviral and nonviral genomes[J].Hum Gene Ther,2003,14(4):329-339.

[5]Post L E,Roizman B.A generalized technique for deletion of specifific genes in large genomes:alpha gene22 of herpes simplex virus 1 is not essential for growth[J].Cell,1981,25(1):227-232.

[6]Almazán F,González J M,Pénzes Z,Izeta A,Calvo E,Plana-Durán J,Enjuanes L.Engineering the largest RNA virus genome as an infectious bacterial artifificial chromosome[J].Proc Natl Acad Sci U S A,2000,97(10):5516-5521.

[7]Domi A,Moss B.Cloning the vaccinia virus genome as a bacterial artifificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells[J].Proc Natl Acad Sci U S A,2002,99(19):12415-12420.

[8]Luckow V A,Lee S C,Barry G F,Olins P O.Effificient generation of infectious recombinant baculoviruses by sitespecifific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli[J].J Virol,1993,67(8):4566-4579.

[9]Messerle M,Crnkovic I,Hammerschmidt W,Ziegler H,Koszinowski U H.Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artifificial chromosome[J].Proc Natl Acad Sci U S A,1997,94(26):14759-14763.

[10]O'connor M,Peifer M,Bender W.Construction of large DNA segments in Escherichia coli[J].Science,1989,244(4910):1307-1312.

[11]Tanaka M,Kagawa H,Yamanashi Y,Sata T,Kawaguchi Y.Construction of an excisable bacterial artifificial chromosome containing a full-length infectious clone of herpes simplex virus type 1:viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo[J].J Virol,2003,77(2):1382-1391.

[12]Zhang Y,Buchholz F,Muyrers J P,Stewart A F.Anew logic for DNA engineering using recombination in Escherichia coli[J].Nat Genet,1998,20(2):123-128.

[13]Bakota L,Brandt R,Heinisch J J.Triple mammalian/yeast/bacterial shuttle vectors for single and combined Lentivirus-and Sindbis virus-mediated infections of neurons[J].Mol Genet Genomics,2012,287 (4):313-324

[14]Ishino Y,Shinagawa H,Makino K,Amemura M,Nakata A.Nucleotide sequence of the iap gene,responsible for alkaline phosphatase isozyme conversion in Escherichia coli,and identification of the gene product[J].J Bacteriol,1987,169(12):5429-5433.

[15]Jansen R,Embden J D,Gaastra W,Schouls L M.Identification of genes that are associated with DNArepeats in prokaryotes[J].Mol Microbiol,2002,43(6):1565-1575.

[16]Mojica F J,Diez-Villasenor C,Garcia-Martinez J,Soria E.Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements[J].J Mol Evol,2005,60(2):174-182.

[17]Barrangou R,Fremaux C,Deveau H,Richards M,Boyaval P,Moineau S,Romero D A,Horvath P.CRISPR provides acquired resistance against viruses in prokaryotes[J].Science,2007,315(5819):1709-1712.

[18]Makarova K S,Wolf Y I,Alkhnbashi O S,Costa F,Shah S A,Saunders S J,Barrangou R,Brouns S J,Charpentier E,Haft D H,Horvath P,Moineau S,Mojica F J,Terns R M,Terns M P,White M F,Yakunin A F,Garrett R A,van der Oost J,Backofen R,Koonin E V.An updated evolutionary classification of CRISPR-Cas systems[J].Nat Rev Microbiol,2015,13(11):722-736.

[19]Deltcheva E,Chylinski K,Sharma C M,Gonzales K,Chao Y,Pirzada Z A,Eckert M R,Vogel J,Charpentier E.CRISPR RNA maturation by transencoded small RNA and host factor RNase III[J].Nature,2011,471(7340):602-607.

[20]Deveau H,Garneau J E,Moineau S.CRISPR/Cas system and its role in phage-bacteria interactions[J].Annu Rev Microbiol,2010,64:475-493.

[21]Gasiunas G,Barrangou R,Horvath P,Siksnys V.Cas9-cr RNA ribonucleoprotein complex mediates specifific DNA cleavage for adaptive immunity in bacteria[J/OL].Proc Natl Acad Sci U S A,2012,109(39):E2579-2586.

[22]Jinek M,Chylinski K,Fonfara I,Hauer M,Doudna JA,Charpentier E.A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity[J].Science,2012,337(6096):816-821.

[23]Cong L,Ran F A,Cox D,Lin S,Barretto R,Habib N,Hsu P D,Wu X,Jiang W,Marraffini L A,Zhang F.Multiplex genome engineering using CRISPR/Cas systems[J].Science,2013,339(6121):819-823.

[24]Wang H,Yang H,Shivalila C S,Dawlaty M M,Cheng A W,Zhang F,Jaenisch R.One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering[J].Cell,2013,153(4):910-918.

[25]Yang H,Wang H,Shivalila C S,Cheng A W,Shi L,Jaenisch R.One-step generation of mice carrying reporter and conditional alleles by CRISPR/Casmediated genome engineering[J].Cell,2013,154(6):1370-1379.

[26]Niu Y,Shen B,Cui Y,Chen Y,Wang J,Wang L,Kang Y,Zhao X,Si W,Li W,Xiang A P,Zhou J,Guo X,Bi Y,Si C,Hu B,Dong G,Wang H,Zhou Z,Li T,Tan T,Pu X,Wang F,Ji S,Zhou Q,Huang X,Ji W,Sha J.Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos[J].Cell,2014,156(4):836-843.

[27]Kou Z,Wu Q,Kou X,Yin C,Wang H,Zuo Z,Zhuo Y,Chen A,Gao S,Wang X.CRISPR/Cas9-mediated genome engineering of the ferret[J].Cell Res,2015,25(12):1372-1375.

[28]Liao H K,Li M,Martinez Martinez L,Izpisua Belmonte J C.Stem cell,CRISPR and HIV[J].Cell Cycle,2015,14(13):1991-1992.

[29]Liao H K,Gu Y,Diaz A,Marlett J,Takahashi Y,Li M,Suzuki K,Xu R,Hishida T,Chang C J,Esteban CR,Young J,Izpisua Belmonte J C.Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1infection in human cells[J].Nat Commun,2015,6:6413.

[30]Li J F,Zhang D,Sheen J.Targeted plant genome editing via the CRISPR/Cas9 technology[J].Methods Mol Biol,2015,1284:239-255.

[31]Ebina H,Misawa N,Kanemura Y,Koyanagi Y.Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus[J].Sci Rep,2013,3:2510.

[32]Hu W,Kaminski R,Yang F,Zhang Y,Cosentino L,Li F,Luo B,Alvarez-Carbonell D,Garcia-Mesa Y,Karn J,Mo X,Khalili K.RNA-directed gene editing specifically eradicates latent and prevents new HIV-1infection[J].Proc Natl Acad Sci U S A,2014,111(31):11461-11466.

[33]Liao H K,Gu Y,Diaz A,Marlett J,Takahashi Y,Li M,Suzuki K,Xu R,Hishida T,Chang C J,Esteban CR,Young J,Izpisua Belmonte J C.Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1infection in human cells[J].Nat Commun,2015,6:6413.

[34]Lebbink R J,de Jong D C,Wolters F,Kruse E M,van Ham P M,Wiertz E J,Nijhuis M.A combinational CRISPR/Cas9 gene-editing approach can halt HIVreplication and prevent viral escape[J].Sci Rep,2017,7:41968.

[35]Wang Q,Liu S,Liu Z,Ke Z,Li C,Yu X,Chen S,Guo D.Genome scales creening identification of Sa Cas9/g RNAs for targeting HIV-1 provirus and suppression of HIV-1 infection[J].Virus Res,2018,250:21-30.

[36]Xiao Q,Guo D,Chen S.Application of CRISPR Cas9based gene editing in HIV-1 AIDS therapy[J].Front Cell Infect Microbiol,2019,9:69.

[37]Bi Y,Sun L,Gao D,Ding C,Li Z,Li Y,Cun W,Li Q.High-efficiency targeted editing of large viral genomes by RNA-guided nucleases[J/OL].PLo SPathog,2014,10(5):e1004090.

[38]Kennedy E M,Kornepati A V,Cullen B R.Targeting hepatitis B virus ccc DNA using CRISPR/Cas9[J].Antiviral Res,2015,123:188-192.

[39]Lin S R,Yang H C,Kuo Y T,Liu C J,Yang T Y,Sung K C,Lin Y Y,Wang H Y,Wang C C,Shen YC,Wu F Y,Kao J H,Chen D S,Chen P.The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo[J/OL].Mol Ther Nucleic Acids,2014,3(8):e186.

[40]Wang J,Xu Z W,Liu S,Zhang R Y,Ding S L,Xie XM,Long L,Chen X M,Zhuang H,Lu F M.Dual g RNAs guided CRISPR/Cas9 system inhibits hepatitis B virus replication[J].World J Gastroenterol,2015,21(32):9554-965.

[41]Zhen S,Hua L,Liu Y H,Gao L C,Fu J,Wan D Y,Dong L H,Song H F,Gao X.Harnessing the clustered regularly interspaced short palindromic repeat(CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus[J].Gene Ther,2015,22(5):404-412.

[42]Dong C,Qu L,Wang H,Wei L,Dong Y,Xiong S.Targeting hepatitis B virus ccc DNA by CRISPR/Cas9nuclease efficiently inhibits viral replication[J].Antiviral Res,2015,118:110-117.

[43]Ramanan V,Shlomai A,Cox D B,Schwartz R E,Michailidis E,Bhatta A,Scott D A,Zhang F,Rice CM,Bhatia S N.CRISPR/Cas9 cleavage of viral DNAefficiently suppresses hepatitis B virus[J].Sci Rep,2015,5:10833.

[44]Sakuma T,Masaki K,Abe-Chayama H,Mochida K,Yamamoto T,Chayama K.Highly multiplexed CRISPR-Cas9-nuclease and Cas9-nickase vectors for inactivation of hepatitis B virus[J].Genes Cells,2016,21(11):1253-1262.

[45]Hu Z,Yu L,Zhu D,Ding W,Wang X,Zhang C,Wang L,Jiang X,Shen H,He D,Li K,Xi L,Ma D,Wang H.Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells[J].Biomed Res Int,2014,2014:612823.DOI:10.1155/2014/612823

[46]Zhen S,Hua L,Takahashi Y,Ding W,Wang X,Zhang C,Wang L,Jiang X,Shen H,He D,Li K,Xi L,Ma D,Wang H.In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9[J].Biochem Biophys Res Commun,2014,450(4):1422-1426.

[47]van Diemen F R,Lebbink R J.CRISPR/Cas9,a powerful tool to target human herpesviruses[J].Cell Microbiol,2017,19(2).DOI:10.1111/cmi.12694

[48]Suenaga T,Kohyama M,Hirayasu K,Arase H.Engineering large viral DNA genomes using the CRISPR-Cas9 system[J].Microbiol Immunol,2014,58(9):513-522.

[49]van Diemen F R,Kruse E M,Hooykaas M J,Bruggeling C E,Schürch A C,van Ham P M,Imhof SM,Nijhuis M,Wiertz E J,Lebbink R J.CRISPR/Cas9-mediated genome editing of herpesviruses limits productive and latent infections[J/OL].PLo S Pathog,2016,12(6):e1005701.

[50]Roehm P C,Shekarabi M,Wollebo H S,Bellizzi A,He L,Salkind J,Khalili K.Inhibition of HSV-1replication by gene editing strategy[J].Sci Rep,2016,6:23146.

[51]Wang D,Wang X W,Peng X C,Xiang Y,Song S B,Wang Y Y,Chen L,Xin V W,Lyu Y N,Ji J,Ma ZW,Li C B,Xin H W.CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research[J].Cancer Gene Ther,2018,25(5-6):93-105.

[52]Wang J,Quake S R.RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection[J].Proc Natl Acad Sci U S A,2014,111(36):13157-13162.

[53]Yuen K S,Chan C P,Kok K H,Jin D Y.Mutagenesis and genome engineering of Epstein-Barr virus in cultured human cells by CRISPR/Cas9[J].Methods Mol Biol,2017,1498:23-31.

[54]Yuen K S,Wang Z M,Wong N M,Zhang Z Q,Cheng T F,Lui W Y,Chan C P,Jin D Y.Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR/Cas9[J].Virus Res,2018,244:296-303.

[55]Gergen J,Coulon F,Creneguy A,Elain-Duret N,Gutierrez A,Pinkenburg O,Verhoeyen E,Anegon I,Nguyen T H,Halary F A,Haspot F.Multiplex CRISPR/Cas9 system impairs HCMV replication by excising an essential viral gene[J/OL].PLo S One,2018,13(2):e0192602.

[56]Tso F Y,West J T,Wood C.Reduction of Kaposi's sarcoma-associated herpesvirus latency using CRISPR-Cas9 to edit the latency-associated nuclear antigen gene[J/OL].J Virol,2019,93(7):e02183-18.

[57]Xu A,Qin C,Lang Y,Wang M,Lin M,Li C,Zhang R,Tang J.A simple and rapid approach to manipulate pseudorabies virus genome by CRISPR/Cas9 system[J].Biotechnol Lett,2015,37(6),1265-1272.

[58]Liang X,Sun L,Yu T,Pan Y,Wang D,Hu X,Fu Z,He Q,Cao G.A CRISPR/Cas9 and Cre/Lox system-based express vaccine development strategy against re-emerging Pseudorabies virus[J].Sci Rep,2016,6:19176.

[59]Ren L Z,Peng Z Y,Ouyang T,Liu X H,Chen X R,Ye L,Fan J W,Ouyang H S,Pang D X,Bai J Y.Subculturing cells have no effect on CRISPR/Cas9-mediated cleavage of UL30 gene in pseudorabies virus[J].Animal Model Exp Med,2018,1(1):74-77.

[60]Peng Z,Ouyang T,Pang D,Ma T,Chen X,Guo N,Chen F,Yuan L,Ouyang H,Ren L.Pseudorabies virus can escape from CRISPR-Cas9-mediated inhibition[J].Virus Res,2016,223:197-205.

[61]于之清,童武,郑浩,李国新,高飞,王涛,梁超,叶超,武吉强,黄勤峰,童光志.使用CRISPR/Cas9技术构建新型重组伪狂犬病毒疫苗的初步研究[J].中国动物传染病学报,2017,25(4):6-12.

[62]Yao,Y,Bassett,A,Nair V.Targeted editing of avian herpesvirus vaccine vector using CRISPR/Cas9nucleases[J].J Vaccine Technol,2016,1:1-7.

[63]Zou Z,Huang K,Wei Y,Chen H,Liu Z,Jin M.Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccineagainst H5N1avian influenza virus and duck tembusu virus infection[J].Sci Rep,2017,7(1):1478.

[64]Tang N,Zhang Y,Pedrera M,Chang P,Baigent S,Moffat K,Shen Z,Nair V,Yao Y.A simple and rapid approach to develop recombinant avian herpesvirus vectored vaccines using CRISPR/Cas9 system[J].Vaccine,2018,36(5):716-722.

[65]Zhang Y,Tang N,Sadigh Y,Baigent S,Shen Z,Nair V,Yao Y.Application of CRISPR/Cas9 gene editing system on MDV-1 genome for the study of gene function[J/OL].Viruses,2018,10(6),E279.

[66]Zhang Y,Luo J,Tang N,Teng M,Reddy V R A P,Moffat K,Shen Z,Nair V,Yao Y.Targeted Editing of the pp38 gene in Marek's disease virus-transformed cell lines using CRISPR/Cas9 system[J/OL].Viruses,2019,11(5),E391.

[67]Yuan M,Gao X,Chard L S,Ali Z Ahmed J,Li Y,Liu P,Lemoine N R,Wang Y.A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9[J].Mol Ther Methods Clin Dev,2015,2:15035.

[68]Yuan M,Zhang W,Wang J,Al Yaghchi C,Ahmed J,Chard L,Lemoine N R,Wang Y.Efficiently editing the vaccinia virus genome by using the CRISPR-Cas9system[J].J Virol,2015,89(9):5176-5179.

[69]Chou Y Y,Krupp A,Kaynor C,Gaudin R,Ma M,Cahir-Mc Farland E,Kirchhausen T.Inhibition of JCPy V infection mediated by targeted viral genome editing using CRISPR/Cas9[J].Sci Rep,2016,6:36921.

[70]Pan Q,Wang J,Gao Y,Cui H,Liu C,Qi X,Zhang Y,Wang Y,Wang X.The natural large genomic deletion is unrelated to the increased virulence of the novel genotype fowl adenovirus 4 recently emerged in China[J/OL].Viruses,2018,10(9):E494.

[71]Borca M V,Holinka L G,Berggren K A,Gladue D P.CRISPR-Cas9,a tool to efficiently increase the development of recombinant African swine fever viruses[J].Sci Rep,2018,8(1):3154.

[72]Price A A,Sampson T R,Ratner H K,Grakoui A,Weiss D S.Cas9-mediated targeting of viral RNA in eukaryotic cells[J].Proc Natl Acad Sci U S A,2015,112(19):6164-6169.